NERVE TESTING

Premier Neuromed Services v. Geico Insurance Company (8/12/2010)
Read Full Decision (.pdf) »
The insurance carrier ordered a peer review, and the reviewing physician concluded that EMGs should not be used to diagnose radiculopathy—rather, they should be used to rule out other diseases. But the arbitrator disagreed noting that EMG and NCV testing has become the “gold standard” in the diagnosis of radiculopathy, and further noting that the medical records indicated the treatment plan was altered as a result of these tests. Thus, the tests were indeed medically necessary.